Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research Article

The Clinical Significance of Circulating Tumour Cells in Breast Cancer and Colorectal Cancer Patients

SIEGFRIED HAUCH, SILKE ZIMMERMANN, SILKE LANKIEWICZ, VEIT ZIEGLSCHMID, OLIVER BÖCHER and WINFRIED HANS ALBERT
Anticancer Research May 2007, 27 (3A) 1337-1341;
SIEGFRIED HAUCH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SILKE ZIMMERMANN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SILKE LANKIEWICZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VEIT ZIEGLSCHMID
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OLIVER BÖCHER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WINFRIED HANS ALBERT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wa{at}adnagen.com
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 27 no. 3A 1337-1341
PMID 
17593628

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received December 19, 2006
  • Revision received March 20, 2007
  • Accepted March 21, 2007
  • Published online May 1, 2007.

Copyright & Usage 
Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. SIEGFRIED HAUCH1,
  2. SILKE ZIMMERMANN1,
  3. SILKE LANKIEWICZ1,
  4. VEIT ZIEGLSCHMID1,
  5. OLIVER BÖCHER2 and
  6. WINFRIED HANS ALBERT1
  1. 1AdnaGen AG, D-30853 Langenhagen, Germany
  2. 2Prionics AG, CH-8952 Schlieren, Switzerland
  1. Correspondence to: Winfried Hans Albert, AdnaGen AG, D-30853 Langenhagen, Germany. Tel: +49 51172595050, Fax: +49 51172595040, e-mail: wa{at}adnagen.com

Statistics from Altmetric.com

Cited By...

  • 45 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 27, Issue 3A
May-June 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Clinical Significance of Circulating Tumour Cells in Breast Cancer and Colorectal Cancer Patients
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
The Clinical Significance of Circulating Tumour Cells in Breast Cancer and Colorectal Cancer Patients
SIEGFRIED HAUCH, SILKE ZIMMERMANN, SILKE LANKIEWICZ, VEIT ZIEGLSCHMID, OLIVER BÖCHER, WINFRIED HANS ALBERT
Anticancer Research May 2007, 27 (3A) 1337-1341;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
The Clinical Significance of Circulating Tumour Cells in Breast Cancer and Colorectal Cancer Patients
SIEGFRIED HAUCH, SILKE ZIMMERMANN, SILKE LANKIEWICZ, VEIT ZIEGLSCHMID, OLIVER BÖCHER, WINFRIED HANS ALBERT
Anticancer Research May 2007, 27 (3A) 1337-1341;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • The potential for liquid biopsies in the precision medical treatment of breast cancer
  • Circulating Tumor Cells in Patients with Breast Cancer: Monitoring Chemotherapy Success
  • Monitoring of Circulating Tumor Cells in Patients Undergoing Surgery for Hepatic Metastases from Colorectal Cancer
  • Cytokeratin-19 and Mammaglobin Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Trials, N0234/336/436/437
  • Circulating Tumor Cells: Evolving Evidence and Future Challenges
  • Google Scholar
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire